French government's new list of devices paid for separately to DRGs (diagnosis-related groups):
This article was originally published in Clinica
Executive Summary
The French health ministry has updated the list of products that are to be reimbursed separately to medical procedures listed under the diagnosis-related group (DRG) scheme. Normally, medical devices have to be funded from the pot of money allocated to a given medical procedure, but where devices are particularly high-tech and expensive, they are usually funded separately. The new list was published in the Journal officiel of February 28, and is aimed at bringing greater continuity between the public and private sector in terms of products that are reimbursed separately or "en sus", the ministry says. The new list replaces the one that was published on March 2005.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.